HLS Therapeutics Inc. (TSX:HLS)

Canada · Delayed Price · Currency is CAD

4.480

-0.020 (-0.44%)

Mar 2, 2026, 10:18 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	56.62M	63.07M	61.47M	60.01M	56.11M
Pharmaceuticals Growth	-10.23%	2.61%	2.43%	6.95%	3.60%
Total	56.62M	63.07M	61.47M	60.01M	56.11M
Total Growth	-10.23%	2.61%	2.43%	6.95%	3.60%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Canada	42.65M	39.29M	37.02M	34.69M	29.41M
Canada Growth	8.54%	6.13%	6.71%	17.95%	8.30%
United States	13.19M	18.47M	19.56M	20.17M	25.50M
United States Growth	-28.61%	-5.59%	-3.01%	-20.90%	-5.56%
Rest of World	788.00K	5.31M	4.88M	5.15M	1.20M
Rest of World Growth	-85.17%	8.79%	-5.09%	330.54%	-
Total	56.62M	63.07M	61.47M	60.01M	56.11M
Total Growth	-10.23%	2.61%	2.43%	6.95%	3.60%

Source: S&P Global Market Intelligence.